Research Briefs: Study Updates From Neuronetics, Edwards
This article was originally published in The Gray Sheet
Executive Summary
Neuronetics starts study enrollment for its NeuroStar transcranial magnetic stimulation to treat postpartum depression. Edwards delays enrollment for Sapien XT Cohort A of the PARTNER II trial. More research news.